ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryAllschwilAlentis Therapeutics AG
Alentis Therapeutics AG Logo
Verified· 4 sources

Alentis Therapeutics AG

Summary

About the company

The core activity of Alentis Therapeutics AG is the development and research of medicines, particularly in the field of fibrosis and cancer treatment with antibody-drug conjugates (ADCs). The company focuses on developing innovative therapies that directly target the cause of the disease and can prevent or reverse the progression of diseases such as fibrosis and cancer.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
2
Anti-Claudin-1 antibody-drug conjugates (ALE.P02, ALE.P03)
Anti-Claudin-1 antibody-drug conjugates for CLDN1+ solid tumors, including squamous cancer indications; first-in-human Phase 1/2 studies are ongoing.
Lixudebart (ALE.F02) for organ fibrosis
First-in-class monoclonal antibody for kidney, liver and lung fibrosis, developed for ANCA-associated vasculitis, advanced liver fibrosis and idiopathic pulmonary fibrosis.
Reviews

Aggregated rating

Aggregated rating
5
of 5

Aggregated from 1 reviews across all connected sources

Sources
GGoogle51
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

November 25, 2025Media
Key leadership roles filled across multiple startups
startupticker.ch
October 17, 2025Media
New leadership drives growth in biotech and AI startups
startupticker.ch
January 4, 2022Media
Alentis Therapeutics launches first-in-human clinical studies
startupticker.ch
July 31, 2020Media
Executives with business acumen to lead startups
startupticker.ch

Knowledge

No knowledge articles yet

Once Alentis Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Alentis Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Alentis Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Alentis Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hegenheimermattweg 167A
4123 Allschwil

At a glance

Legal form
Corporation
UID
CHE-227.760.145
Founded
2019 · 7 years
Last commercial register change
June 8, 2026
Employees
21 to 50

Similar companies

AP
Abbott Products Operations AG
Allschwil
AP
Actelion Pharmaceuticals Ltd
Allschwil
AT
Alloy Therapeutics (Switzerland) AG
Allschwil
IP
Idorsia Pharmaceuticals Ltd
Allschwil
WA
Weleda AG
Arlesheim
GP
Gebro Pharma AG
Liestal
SP
Santhera Pharmaceuticals (Schweiz) AG
Pratteln
WH
Weleda Healthcare AG
Arlesheim